Financials data is unavailable for this security.
View more
Year on year ImmuPharma PLC had revenues remain flat at 0.00, though the company grew net income from a loss of 3.81m to a smaller loss of 2.92m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -66.99% |
---|---|
Return on equity | -111.20% |
Return on investment | -111.20% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at ImmuPharma PLC fell by 459.33k. Cash Flow from Financing totalled 722.10k or -- of revenues. In addition the company used 1.36m for operations while cash from investing totalled 188.76k.
Cash flow per share | -0.0063 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0065 |
---|---|
Tangible book value per share | 0.0054 |
More ▼
Balance sheet in GBPView more
Current ratio | 1.60 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼